Multi-Institutional Retrospective Study for the Efficacy of ICIs plus Platinum-Based Chemotherapy for EGFR Mutated NSCLC

被引：0
|
作者：
Kataoka, S. [1 ]
Miyawaki, T. [1 ]
Motojima, M. [2 ]
Shibayama, K. [1 ]
Nanba, Y. [2 ]
Mimori, T. [1 ]
Shukuya, T. [1 ]
Shimada, N. [1 ]
Koyama, R. [3 ]
Kido, K. [3 ]
Sasaki, S. [2 ]
Takahashi, K. [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[2] Juntendo Univ, Urayasu Hosp, Chiba, Japan
[3] Juntendo Univ, Nerima Hosp, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR mutated NSCLC; ICIs; retrospective study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-04
引用
收藏
页码：S620 / S620
页数：1
相关论文
共 50 条
  • [31] IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients
    Nishio, Makoto
    Saito, Haruhiro
    Goto, Koichi
    Watanabe, Satoshi
    Sueoka-Aragane, Naoko
    Okuma, Yusuke
    Kasahara, Kazuo
    Chikamori, Kenichi
    Nakagawa, Yuki
    Kawakami, Tomohisa
    CANCER SCIENCE, 2021, 112 (04) : 1534 - 1544
  • [32] Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysis
    Chen, Juan
    Wang, Zhan
    Zou, Ting
    Cui, Jiajia
    Yin, Jiye
    Zheng, Wei
    Jiang, Wuzhong
    Zhou, Honghao
    Liu, Zhaoqian
    ONCOTARGET, 2016, 7 (34) : 55741 - 55756
  • [33] Efficacy of regorafenib in metastatic colorectal cancer: A multi-institutional retrospective study
    Bazarbashi, M. S.
    Elshenawy, M. A.
    Kandil, M. S.
    Zahir, M.
    Shaheen, A.
    Gad, A.
    Alshaer, O.
    Alzahrani, A. M.
    Eldali, A.
    Aljubran, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and EGFR-Mutated Lung Adenocarcinoma
    Tambo, Yuichi
    Sone, Takashi
    Kasahara, Kazuo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (12) : E199 - E200
  • [35] Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
    Aljubran, Ali
    Elshenawy, Mahmoud A.
    Kandil, Magdy
    Zahir, Muhammed N.
    Shaheen, Ahmed
    Gad, Ahmed
    Alshaer, Omar
    Alzahrani, Ahmed
    Eldali, Abdelmonem
    Bazarbashi, Shouki
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
  • [36] A Randomized Phase II Study of Platinum-Based Chemotherapy plus /-Metformin in Chemotherapy-Naive Advanced Non-Squamous NSCLC
    Marrone, Kristen
    Forde, Patrick
    Brahmer, Julie
    Rosner, Gary
    Zhou, Xian
    Coleman, Barbara
    Ettinger, David
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S893 - S893
  • [37] Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis
    Zhang, C.
    Yi, D. -C.
    Sun, Y. -X.
    Jiang, B. -Y.
    Yan, L. -X.
    Peng, L. -S.
    Liu, S. -Y.
    Yang, J.
    Sun, H.
    Peng, D.
    Li, Y. -S.
    Chen, S. -A.
    Liao, R. -Q.
    Yang, X. -N.
    Zhou, Q.
    Wu, Y. -L.
    Zhang, Z. -M.
    Zhong, W. -Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S284 - S284
  • [38] THE EFFICACY OF PLATINUM-BASED ADJUVANT CHEMOTHERAPY ACCORDING TO EGFR MUTATION IN THE SURGICALLY RESECTED LUNG ADENOCARCINOMAS
    Kang, Jin Hyoung
    Kim, In-Ho
    Kim, Jung Oh
    Kim, Tae-Jung
    Hong, Sook Hee
    Jeon, Eun Kyoung
    Lee, Kyo-Young
    Sung, Sook Hwan
    Park, Jae Kil
    Kim, Seung Joon
    Kim, Young Kyoon
    Kim, Hoon-Kyo
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S185 - S186
  • [39] Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma
    Souichi Yanamoto
    Masahiro Umeda
    Mitomu Kioi
    Tadaaki Kirita
    Tetsuro Yamashita
    Hiroyoshi Hiratsuka
    Satoshi Yokoo
    Hideki Tanzawa
    Narikazu Uzawa
    Takahiko Shibahara
    Yoshihide Ota
    Hiroshi Kurita
    Masaya Okura
    Hiroyuki Hamakawa
    Jingo Kusukawa
    Iwai Tohnai
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 549 - 554
  • [40] Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma
    Yanamoto, Souichi
    Umeda, Masahiro
    Kioi, Mitomu
    Kirita, Tadaaki
    Yamashita, Tetsuro
    Hiratsuka, Hiroyoshi
    Yokoo, Satoshi
    Tanzawa, Hideki
    Uzawa, Narikazu
    Shibahara, Takahiko
    Ota, Yoshihide
    Kurita, Hiroshi
    Okura, Masaya
    Hamakawa, Hiroyuki
    Kusukawa, Jingo
    Tohnai, Iwai
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (03) : 549 - 554
12345